7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients with Gastric Cancer

      research-article
      1 , 1 , 2 , 1 , 2 , 2 , 3 , 4 , 5 , 6 , 7 , 2 , 8 , 8 , 9 , 9 , 9 , 10 , 10 , 11 , 12 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , Latin American Gastric Cancer Genetics Collaborative Group 19 , 16 , 16 , 5 , 2 , 3 , 5 , 20 , 1 , 21
      Gastroenterology
      stomach, tumor, WES, interaction

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.

          Related collections

          Author and article information

          Journal
          0374630
          3841
          Gastroenterology
          Gastroenterology
          Gastroenterology
          0016-5085
          1528-0012
          24 December 2016
          23 December 2016
          April 2017
          01 April 2018
          : 152
          : 5
          : 983-986.e6
          Affiliations
          [1 ]Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, USA
          [2 ]Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia
          [3 ]Fundación Pública Galega de Medicina Xenómica (FPGMX), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Genomics Medicine Group, Hospital Clínico, 15706 Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain
          [4 ]Servicio de Anatomía Patológica, Hospital Clínico, Santiago de Compostela, Spain
          [5 ]Department of Genetics, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal
          [6 ]Unidad de Investigación en Enfermedades Infecciosas, UMAE Pediatria, IMSS, México City, México
          [7 ]Departamento de Patologia, UMAE Oncologia, IMSS, Mexico City, Mexico
          [8 ]Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
          [9 ]Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
          [10 ]Universidad de Antioquia, Medellin, Colombia
          [11 ]INBIOMED, UBA/CONICET y CEMIC, CABA, Argentina
          [12 ]Laboratorio GENIA, Montevideo, Uruguay
          [13 ]Wellcome Trust Centre for Human Genetics, University of Oxford, UK
          [14 ]Centro de Genética Médica Dr. Jacinto Magalhães (CGMJM), Centro Hospitalar do Porto, Porto, Portugal
          [15 ]Department of Pathology, School of Medicine, University of California, Davis, USA
          [16 ]Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
          [17 ]Yangcheng Cancer Hospital, Yangcheng, Shanxi, PR China
          [18 ]Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China
          [19 ]Full details listed in the acknowledgements
          [20 ]Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal
          [21 ]Fundación de Genómica y Genética Molecular, Colombia
          Author notes
          Corresponding Author: Luis G. Carvajal-Carmona, PhD Genome Center and Department of Biochemistry and Molecular Medicine School of Medicine, University of California, Davis UC Davis Genome Center, 451 Health Sciences Drive Davis, California 95616, USA Phone: +1 530-752-9654, Fax: +1 530-754-9658 lgcarvajal@ 123456ucdavis.edu
          [*]

          These authors contributed equally to the manuscript

          [a]

          In memoriam

          Article
          PMC5367981 PMC5367981 5367981 nihpa838951
          10.1053/j.gastro.2016.12.010
          5367981
          28024868
          cdfddc86-1abc-430f-8edc-b858e2a4771a
          History
          Categories
          Article

          interaction,stomach,tumor,WES
          interaction, stomach, tumor, WES

          Comments

          Comment on this article